Stocktoria
Rein Therapeutics, Inc. RNTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2017-06-29
Rein Therapeutics, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| VON RICKENBACH JOSEF H | director | 2026-05-27 | Buy | 4,500 | $1.07 |
| VON RICKENBACH JOSEF H | director | 2026-05-26 | Buy | 23,190 | $1.06 |
| VON RICKENBACH JOSEF H | director | 2026-05-22 | Buy | 15,950 | $1.05 |
| VON RICKENBACH JOSEF H | director | 2026-05-21 | Buy | 3,420 | $1.04 |
| WINDSOR JAMES BRIAN | See Remarks | 2026-04-30 | Buy | 25,000 | $1.00 |
| Voss Capital, LP | 10% owner | 2025-11-14 | Buy | 104,183 | $1.22 |
| Voss Capital, LP | 10% owner | 2025-10-28 | Buy | 178,392 | $1.39 |
| Voss Capital, LP | 10% owner | 2025-10-27 | Buy | 92,642 | $1.37 |
Source: SEC EDGAR filings · CIK 0001420565 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.